A detailed history of Commonwealth Equity Services, LLC transactions in Dyadic International Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 32,164 shares of DYAI stock, worth $54,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,164
Previous 31,164 3.21%
Holding current value
$54,678
Previous $46,000 28.26%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1.04 - $1.55 $1,040 - $1,550
1,000 Added 3.21%
32,164 $33,000
Q2 2024

Jul 31, 2024

BUY
$1.39 - $2.27 $2,260 - $3,691
1,626 Added 5.5%
31,164 $46,000
Q1 2024

Apr 29, 2024

BUY
$1.29 - $1.67 $1,755 - $2,272
1,361 Added 4.83%
29,538 $49,000
Q4 2023

Feb 06, 2024

SELL
$1.52 - $2.04 $829 - $1,113
-546 Reduced 1.9%
28,177 $45,000
Q3 2023

Oct 23, 2023

BUY
$1.71 - $2.08 $1,800 - $2,190
1,053 Added 3.81%
28,723 $55,000
Q2 2023

Aug 10, 2023

BUY
$1.56 - $2.38 $1,472 - $2,246
944 Added 3.53%
27,670 $53,000
Q3 2022

Nov 14, 2022

SELL
$1.65 - $3.42 $1,815 - $3,762
-1,100 Reduced 3.95%
26,726 $51,000
Q2 2022

Jul 19, 2022

SELL
$1.85 - $3.22 $355 - $618
-192 Reduced 0.69%
27,826 $84,000
Q1 2022

May 04, 2022

BUY
$3.01 - $4.81 $23,026 - $36,796
7,650 Added 37.56%
28,018 $84,000
Q4 2021

Jan 31, 2022

BUY
$3.36 - $5.34 $24,212 - $38,480
7,206 Added 54.75%
20,368 $92,000
Q3 2021

Oct 29, 2021

SELL
$3.3 - $6.49 $20,955 - $41,211
-6,350 Reduced 32.54%
13,162 $73,000
Q2 2021

Aug 11, 2021

BUY
$3.35 - $5.67 $65,365 - $110,633
19,512 New
19,512 $70,000
Q1 2021

May 04, 2021

SELL
$4.75 - $6.87 $60,743 - $87,853
-12,788 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$5.35 - $7.77 $68,415 - $99,362
12,788 New
12,788 $68,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $48.3M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.